Literature DB >> 22126705

Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels.

Diana Kadetoff1, Jon Lampa, Marie Westman, Magnus Andersson, Eva Kosek.   

Abstract

Activation of glia cells resulting in intrathecal elevation of cytokines and chemokines has been hypothesized in chronic pain syndromes such as fibromyalgia. To our knowledge, this is the first study assessing intrathecal concentrations of pro-inflammatory substances in fibromyalgia. We report elevated cerebrospinal fluid and serum concentrations of interleukin-8, but not interleukin-1beta, in FM patients. This profile is in accordance with FM symptoms being mediated by sympathetic activity rather than dependent on prostaglandin associated mechanisms and supports the hypothesis of glia cell activation in response to pain mechanisms.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126705     DOI: 10.1016/j.jneuroim.2011.10.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  59 in total

Review 1.  Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults.

Authors:  Sheena Derry; Philip J Wiffen; Winfried Häuser; Martin Mücke; Thomas Rudolf Tölle; Rae F Bell; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-03-27

2.  Evidence for brain glial activation in chronic pain patients.

Authors:  Marco L Loggia; Daniel B Chonde; Oluwaseun Akeju; Grae Arabasz; Ciprian Catana; Robert R Edwards; Elena Hill; Shirley Hsu; David Izquierdo-Garcia; Ru-Rong Ji; Misha Riley; Ajay D Wasan; Nicole R Zürcher; Daniel S Albrecht; Mark G Vangel; Bruce R Rosen; Vitaly Napadow; Jacob M Hooker
Journal:  Brain       Date:  2015-01-12       Impact factor: 13.501

3.  Immunomodulatory effects of coated gold nanoparticles in LPS-stimulated in vitro and in vivo murine model systems.

Authors:  Daniel F Moyano; Yuanchang Liu; Furkan Ayaz; Singyuk Hou; Premsak Puangploy; Bradley Duncan; Barbara A Osborne; Vincent M Rotello
Journal:  Chem       Date:  2016-08-11       Impact factor: 22.804

Review 4.  Neurogenic inflammation in fibromyalgia.

Authors:  Geoffrey Littlejohn; Emma Guymer
Journal:  Semin Immunopathol       Date:  2018-03-19       Impact factor: 9.623

5.  Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Benjamin H Natelson; Diana Vu; Xiangling Mao; Nora Weiduschat; Fumiharu Togo; Gudrun Lange; Michelle Blate; Guoxin Kang; Jeremy D Coplan; Dikoma C Shungu
Journal:  J Pain       Date:  2015-08-31       Impact factor: 5.820

Review 6.  Fibromyalgia syndrome in need of effective treatments.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Lauren Arbetman; Smaro Panagiotidou; Julia M Stewart; Rae M Gleason; Irwin J Russell
Journal:  J Pharmacol Exp Ther       Date:  2015-08-25       Impact factor: 4.030

7.  Overlapping structural and functional brain changes in patients with long-term exposure to fibromyalgia pain.

Authors:  Karin B Jensen; Priti Srinivasan; Rosa Spaeth; Ying Tan; Eva Kosek; Frank Petzke; Serena Carville; Peter Fransson; Hanke Marcus; Steven C R Williams; Ernest Choy; Olivier Vitton; Richard Gracely; Martin Ingvar; Jian Kong
Journal:  Arthritis Rheum       Date:  2013-12

8.  Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation.

Authors:  Takako Miyamae; Manabu Seki; Tomoko Naga; Shinya Uchino; Haruki Asazuma; Takuma Yoshida; Yuki Iizuka; Masako Kikuchi; Tomoyuki Imagawa; Yutaka Natsumeda; Shumpei Yokota; Yorihiro Yamamoto
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

Review 9.  Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome.

Authors:  Geoffrey Littlejohn
Journal:  Nat Rev Rheumatol       Date:  2015-08-04       Impact factor: 20.543

Review 10.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.